NCT00332748View on ClinicalTrials.gov

A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2007

Conditions
Cancer
Interventions
DRUG

Oral Taxane

Trial Locations (4)

Unknown

Local Institution, Newark

Local Institution, Louisville

Local Institution, Las Vegas

Local Institution, Amsterdam

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00332748 - A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter